Unclaimed Scholar Profile
Are you Erica Maxine Lazarus? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of the WitwatersrandASIDASID-9298-4234-7611 orcid.org/0000-0002-4965-0624
Erica Maxine Lazarus
University of the Witwatersrand•South Africa
Faculty researcher at University of the Witwatersrand (ZA), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Policy & Economics Specialist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#HIV/AIDS Research and Interventions#HIV Research and Treatment#SARS-CoV-2 and COVID-19 Research#HIV/AIDS drug development and treatment
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 8,269 | 3,969 |
| h-index | 22 | 17 |
| i10-index | 29 | 20 |
Annual Citation Growth
Verified Citations / Year0
2020397
2021+40%556
2022+28%714
2023+33%953
2024-8%873
2025-45%476
2026Scholarship Distribution & Proportions46 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (6,781) • 18% Global Research Impact (1,488)
46 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (46)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
DOI: 10.1016/s0140-6736(20)32661-1 Verified Peer-Reviewed
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
Published in The Lancet•2021
DOI: 10.1016/s0140-6736(21)00432-3 Verified Peer-Reviewed
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2031738 Verified Peer-Reviewed
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
Published in The Lancet•2018
DOI: 10.1016/s0140-6736(18)31364-3 Verified Peer-Reviewed
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial
Published in The Lancet•2013
DOI: 10.1016/s0140-6736(13)61409-9 Verified Peer-Reviewed
Showing 1 – 5 of 46 publications
1 / 10